Harbin Pharmaceutical Group Co. Ltd. logo

Harbin Pharmaceutical Group Co. Ltd. (600664)

Market Open
10 Aug, 06:57
SSE SSE
¥
7. 52
+0.68
+9.9415%
¥
9.07B Market Cap
- P/E Ratio
2% Div Yield
131.76M Volume
- Eps
¥ 6.84
Previous Close
Add Transaction
Day Range
7.4 7.52
Year Range
2.84 7.52
Want to track 600664 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

600664 trading today higher at ¥7.52, an increase of 9.9415% from yesterday's close, completing a monthly increase of 152.349% or ¥4.54. Over the past 12 months, 600664 stock gained 117.971%.
600664 is not paying dividends to its shareholders.
The last earnings report, released on Apr 25, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Harbin Pharmaceutical Group Co. Ltd. has completed 8 stock splits, with the recent split occurring on Apr 06, 2016.
The company's stock is traded on one exchange.

600664 Chart

People also search for

Shanghai Haoyuan Chemexpress Co., Ltd.
¥ 98.08
+0.3581%
Changchun BCHT Biotechnology Co., Ltd.
¥ 15.99
0%
Zhejiang Taihua New Material Co., Ltd.
¥ 8.6
+1.8957%
Ningbo Fujia Industrial Co., Ltd.
¥ 14.55
+1.3231%
Xiamen King Long Motor Group Co., Ltd.
¥ 12.44
+2.6403%

Harbin Pharmaceutical Group Co. Ltd. (600664) FAQ

What is the stock price today?

The current price is ¥7.52.

On which exchange is it traded?

Harbin Pharmaceutical Group Co. Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 600664.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2%.

What is its market cap?

As of today, the market cap is 9.07B.

Has Harbin Pharmaceutical Group Co. Ltd. ever had a stock split?

Harbin Pharmaceutical Group Co. Ltd. had 8 splits and the recent split was on Apr 06, 2016.

Harbin Pharmaceutical Group Co. Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Bo Jiang CEO
SSE Exchange
CNE0000009T3 ISIN
CN Country
9,853 Employees
4 May 2018 Last Dividend
6 Apr 2016 Last Split
1 Feb 1990 IPO Date

Overview

Harbin Pharmaceutical Group Co., Ltd., based in Harbin, China, is a prominent entity in the pharmaceutical industry, recognized for its extensive involvement in the research, development, manufacture, and trading of pharmaceuticals both domestically and internationally. With a focus on innovation and quality, the company has established a strong presence in the healthcare sector by providing a wide range of pharmaceutical products designed to meet the diverse needs of patients worldwide.

Products and Services

The company's product portfolio is extensive and diversified, covering various therapeutic areas. These include:

  • Blood and Hematopoietic: Products aimed at treatments for blood disorders, enhancing the body's ability to produce blood.
  • Antineoplastic and Immunomodulatory: Offering treatments for cancer and other related conditions by targeting abnormal cell growth and modulating the immune system.
  • Respiratory: Medications designed to address respiratory ailments, improving breathing and treating lung conditions.
  • Anti-inflammatory and Analgesic: Drugs that help reduce inflammation and relieve pain, catering to conditions such as arthritis, menstrual pain, and other inflammatory diseases.
  • Chronic Diseases: A range of products tailored for the management and treatment of long-term conditions such as diabetes, hypertension, and heart disease.
  • Mineral Supplements: Supplements to prevent or correct mineral deficiencies in the body, contributing to overall health and well-being.
  • Chinese Medicines: Traditional Chinese medicinal products, leveraging age-old formulas and natural ingredients for a variety of health benefits.
  • Antibiotics: A crucial line of defense against bacterial infections, available in various forms to treat a wide array of infections.

These products are made available under several reputable brands including Harbin Pharmaceutical, Sanjing, Gaizhonggai, Hutong, and Shiyitang, reflecting the company's commitment to quality and patient care.

Contact Information

Address: No. 7, Qunli Avenue, Harbin, China, 150070
Phone: 86 45 1518 70240